Physician profile
Audrey Moruzzi
NPI 1598021420
$1,419.44
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $118 · 2021: $206 · 2022: $104 · 2023: $170 · 2024: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $455.41 | 2019-2024 | |
| Therapeuticsmd, INC. | $284.18 | 2019-2022 | |
| Exeltis, USA INC. | $142.52 | 2019-2024 | Slynd |
| Allergan, INC. | $108.68 | 2019 | |
| Astellas Pharma US INC | $98.75 | 2024 | Veozah |
| Pfizer INC. | $53.46 | 2019-2024 | |
| Evofem Biosciences, INC. | $45.96 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.14 | 2019-2020 | |
| Agile Therapeutics, INC. | $37.59 | 2023-2024 | Twirla |
| Coopersurgical, INC. | $33.77 | 2023 | Paragard T 380a |
| Myovant Sciences INC. | $33.18 | 2021 | |
| Organon LLC | $22.17 | 2024 | |
| Hologic Sales and Service, LLC | $18.63 | 2024 | Aptima |
| Aspira Women'S Health INC | $16.43 | 2022 | |
| Merck Sharp & Dohme LLC | $16.25 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $14.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Moruzzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.